Authors: Vincent-Salomon, A Carton, M Freneaux, P Palangie, T Beuzeboc, P Mouret, E de Cremoux, P Coue, O Zafrani, B Nicolas, A Clough, K Fourquet, A Pouillart, P Sastre-Garau, X

Citation: A. Vincent-salomon et al., ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy, EUR J CANC, 36(5), 2000, pp. 586-591

Authors: Couturier, J Vincent-Salomon, A Nicolas, A Beuzeboc, P Mouret, E Zafrani, B Sastre-Garau, X

Citation: J. Couturier et al., Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma, MOD PATHOL, 13(11), 2000, pp. 1238-1243

Authors: Zafrani, B Aubriot, MH Mouret, E de Cremoux, P de Rycke, Y Nicolas, A Boudou, E Vincent-Salomon, A Magdelenat, H Sastre-Garau, X

Citation: B. Zafrani et al., High sensitivity and specificity of immunohistochemistry for the detectionof hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases, HISTOPATHOL, 37(6), 2000, pp. 536-545

Authors: Pierga, JY Mouret, E Dieras, V Laurence, V Beuzeboc, P Dorval, T Palangie, T Jouve, M Vincent-Salomon, A Scholl, S Extra, JM Asselain, B Pouillart, P

Citation: Jy. Pierga et al., Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer, BR J CANC, 83(11), 2000, pp. 1480-1487

Authors: Freneaux, P Stoppa-Lyonnet, D Mouret, E Kambouchner, M Nicolas, A Zafrani, B Vincent-Salomon, A Fourquet, A Magdelenat, H Sastre-Garau, X

Citation: P. Freneaux et al., Low expression of bcl-2 in Brca1-associated breast cancers, BR J CANC, 83(10), 2000, pp. 1318-1322